查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493302

美国心臟去颤器市场规模、份额和趋势分析报告：按产品、最终用途和细分市场预测，2024-2030 年

U.S. Defibrillator Market Size, Share & Trends Analysis Report By Product (Implantable Cardioverter Defibrillators, External Defibrillators), By End-Use (Hospital, Pre-hospital), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国心臟去颤器市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年美国心臟去颤器市场规模将达43.2亿美元，2024年至2030年复合年增长率为7.3%。

技术进步的不断进步、心臟麻痹和心血管疾病发生率的上升、新兴应用的采用不断增加以及政府和医疗机构的支持倡议是推动该行业增长的一些关键因素。

美国心血管疾病盛行率上升是美国心臟去颤器市场的主要动力。例如，根据美国疾病管制与预防中心 (CDC) 的数据，心房颤动 (AFib) 是美国每年约 454,000 例住院患者的首要诊断。这种健康状况每年导致约 158,000 人死亡。心血管疾病的这种上升趋势预计将有助于预测期内的市场成长。

老年人口的增加和技术进步预计将对市场成长产生重大影响。 65岁及以上的老年人更容易患心血管疾病（CVD）等慢性疾病。例如，根据 2022 年 11 月题为《老化人口统计：老龄化美国的肖像》的报导，美国约有 5,410 万人（16.3%）的年龄为 65 岁。因此，不断增长的老年人口正在推动对这些产品的需求。

美国心臟去颤器市场报告亮点

  • 2023 年，植入式心臟整流去颤器(ICD) 占据市场主导地位，比重超过 50%。推动此细分市场成长的关键因素包括心血管疾病的高盛行率、主要市场中老年人口众多，以及由于产品应用范围扩大和技术进步而越来越多地采用这些设备。
  • 2023年，医院部门占销售额的最大份额，因为医院的心臟病病例数量很高，而且手术也在医院进行。
  • 由于增加公共使用 AED 可用性的倡议不断增多，预计 2024 年至 2030 年的复合年增长率将是公共使用市场领域最快的。
  • 美国心臟去颤器市场的参与者包括美敦Medtronic）、雅培（Abbott）、波士顿科学公司（Boston Scientific Corporation）、百多力（BIOTRONIK SE &Co.KG）、微创科学公司（MicroPort Scientific Corporation） 、皇家飞利浦公司（Koninklijke Philips NV）、史赛克（Stryker）、ZOLL Medical Corporation（旭化成）、工业, Ltd.）和西门子医疗保健公司。
  • 2024 年 2 月，植入式医疗设备领域的知名公司 BIOTRONIK 宣布，决定独家提供其创新的 DX 型号，用于未来的单腔 ICD 植入。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国心臟去颤器市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国心臟去颤器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国心臟去颤器市场：产品预估及趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 美国心臟去颤器市场：按产品分類的前景
  • 2018-2030年市场规模及预测及趋势分析

第五章美国心臟去颤器市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的美国心臟去颤器市场前景
  • 2018-2030年市场规模及预测及趋势分析

第六章 竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • List of key distributors and channel partners
    • Key customers
    • 2023年重点公司热图分析
  • 公司简介
    • Medtronic
    • Koninklijke Philips NV
    • Siemens Healthineers
    • Abbott
    • Boston Scientific Corporation
    • BIOTRONIK SE &Co. KG
    • MicroPort Scientific Corporation
    • Nihon Kohden Corporation
    • Stryker
Product Code: GVR-4-68040-277-4

U.S. Defibrillator Market Growth & Trends:

The U.S. defibrillator market size is anticipated to reach USD 4.32 billion by 2030, exhibiting a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing technological advancements, rising incidence of sudden cardiac arrest and CVD's, rising adoption in emerging applications, and supportive initiatives by governments & healthcare organizations are some of the key factors fueling industry growth.

The escalating prevalence of cardiovascular diseases in the U.S. serves as a major driving force for the U.S. defibrillator market. For instance, as per the Centers for Disease Control and Prevention (CDC), around 454,000 hospitalizations annually in the U.S. involve Atrial Fibrillation (AFib) as the primary diagnosis. This health condition contributes to around 158,000 annual deaths. This rising trend of cardiovascular diseases is expected to contribute to market growth during the forecast period.

The rising geriatric population and technological advancements are expected to significantly impact market growth. Individuals aged 65 years and above are highly prone to chronic illnesses such as cardiovascular diseases (CVDs). For instance, a November 2022 article titled "Senior Population Statistics: A Portrait of Aging Americans" revealed that approximately 54.1 million (16.3%) people in the U.S. are 65 years or older. Consequently, the growing geriatric population drives the demand for these products.

U.S. Defibrillator Market Report Highlights:

  • Implantable cardioverter defibrillators (ICDs) dominated the market with a share of more than 50% in 2023. Key factors driving this segment growth include the rising adoption of these devices due to the high prevalence of CVDs, the high geriatric population in key markets, and growing product applications and technological advancement.
  • Hospital segment held the largest revenue share in 2023 owing to the higher volume of cardiac cases in hospitals and surgeries performed in hospital settings.
  • The public access market segment is anticipated to register the fastest CAGR from 2024 to 2030 due to the rising initiatives to increase the availability of public access AEDs.
  • Market players operating in the U.S. defibrillator market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Koninklijke Philips N.V., Stryker, ZOLL Medical Corporation (Asahi Kasei), Nihon Kohden Corporation, and Siemens Healthineers.
  • In February 2024, BIOTRONIK, a prominent company in the field of implantable medical devices, declared its decision to exclusively provide their innovative DX models for future single-chamber ICD implantations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-Use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Defibrillator Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing technological advancements
      • 3.2.1.2. Rising incidence of sudden cardiac arrest and CVD's
      • 3.2.1.3. Supportive initiatives by governments & healthcare organizations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
  • 3.3. U.S. Defibrillator Market Analysis Tools
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Supplier power
      • 3.2.3.2. Buyer power
      • 3.2.3.3. Substitution threat
      • 3.2.3.4. Threat of new entrant
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.3.1. Political landscape
      • 3.2.3.2. Technological landscape
      • 3.2.3.3. Economic landscape

Chapter 4. U.S. Defibrillator Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Defibrillator Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Implantable cardioverter defibrillators (ICD)
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. S-ICD
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. T-ICD
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.2. Single chamber
      • 4.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.3. Dual chanmber
      • 4.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.4. CRT-D
      • 4.4.1.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. External defibrillators
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Manual ED
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Automated ED
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Wearable cardoverter defribrillators
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Defibrillator Market: End-Use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Defibrillator Market by End-Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospital
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Pre-hospital
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Public access market
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Alternate care market
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Home healthcare
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Medtronic
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Koninklijke Philips N.V.
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Siemens Healthineers
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Abbott
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Boston Scientific Corporation
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. BIOTRONIK SE & Co. KG
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. MicroPort Scientific Corporation
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Nihon Kohden Corporation
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Stryker
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. defibrillators market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. defibrillators market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. defibrillators market: Market outlook
  • Fig. 9 U.S. defibrillators competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. defibrillators market driver impact
  • Fig. 14 U.S. defibrillators market restraint impact
  • Fig. 15 U.S. defibrillators market: Product movement analysis
  • Fig. 16 U.S. defibrillators market: Product outlook and key takeaways
  • Fig. 17 Implantable cardioverter defibrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 S-ICD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 T-ICD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Single chamber market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Dual chamber market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 CRT-D market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 External defibrillators estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Manual ED market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Automated ED market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Wearable cardioverter defribrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. defibrillators market: End-Use movement analysis
  • Fig. 28 U.S. defibrillators market: End use outlook and key takeaways
  • Fig. 29 Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Pre-hospital market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 31 Public access market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 32 Alternate care market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 33 Home healthcare market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 34 Market share of key market players - U.S. defibrillators market